Exane BNP Paribas Upgrades Medical Properties Trust to Outperform, Raises Price Target to $9

Benzinga · 03/12 09:47
Exane BNP Paribas analyst Nate Crossett upgrades Medical Properties Trust (NYSE:MPW) from Neutral to Outperform and raises the price target from $5 to $9.